Page 18 - Stroke Statistics News Today

 E-Mail DALLAS, April 6, 2021 -- A tsunami of chronic health conditions as a result of the SARS-CoV-2 pandemic, especially cardiometabolic disease, may produce an enormous wave of death and disability that demands immediate, comprehensive strategies. In addition, COVID-19 has disrupted cardiovascular science and medicine, yet it presents opportunities to transform and create novel approaches that can yield new successes. These are the opinions of two esteemed leaders in cardiovascular disease ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. VASCEPA® (Icosapent Ethyl) Found in Prespecified and Post Hoc Analyses to Significantly Reduce ... Amarin Corporation plcMarch 17, 2021 GMT 28% and 32% significant reductions in first and total strokes, respectively, demonstrated with VASCEPA compared to placebo, as well as reductions in first and total ischemic strokes each by 36%, without increasing hemorrhagic stroke, in statin-treated patients wi...

Share: 28% and 32% significant reductions in first and total strokes, respectively, demonstrated with VASCEPA compared to placebo, as well as reductions in first and total ischemic strokes each by 36%, without increasing hemorrhagic stroke, in statin-treated patients with elevated cardiovascular risk Consistent reductions in overall stroke and in ischemic stroke observed across multiple subgroups Administration of pure icosapent ethyl, VASCEPA, represents a novel clinical approach to stroke re...

Share this article Share this article NEW YORK, March 15, 2021 /PRNewswire/ -- One of the key reasons behind the growth of the global  external defibrillator market is the rise in the prevalence of cardiovascular diseases (CVDs). As a result, the revenue generated from the sale of such devices is predicted to reach $9,450.3 million by 2030, from $3,926.5 million in 2019, at an 8.5% CAGR between 2020 and 2030, according to P&S Intelligence. According to the Heart Disease and Stroke Statistics�...

Pharmacists must ascertain the appropriateness of use and screen for potential contraindications and drug interactions.

#GoRedForWomen: National Wear Red Day raises awareness of heart health Cardiovascular disease leading killer of women in the US Tags:  Are you familiar with the connection between your cardiovascular health and COVID-19? (Photo used with permission from Heart & Vascular Institute) DETROIT – Cardiovascular disease is the leading killer of women in the United States, according to the American Heart Association. According to the association’s newly released 2021 Heart Disease and Stroke Stati...

February is  Heart Awareness Month. Thats good. We need to be as aware as possible of these ticking keepers of life pumping inside of our bodies. According to the  American Heart Associations 2019 Heart Disease and Stroke Statistics report, heart-related disease remains the top cause of death for Americans. Want a grim statistic? Linda R. Bernstein, Pharm D. of  Vita Media Corporation recently confirmed the data showing that someone in the United States has a  heart attack every 40 secon...

 E-Mail DALLAS, Jan. 27, 2021 -- Heart disease remains the leading cause of death worldwide, according to the American Heart Associations Heart Disease and Stroke Statistics -- 2021 Update, published today in the Associations flagship journal Circulation, and experts warn that the broad influence of the COVID-19 pandemic will likely continue to extend that ranking for years to come. Globally, nearly 18.6 million people died of cardiovascular disease in 2019, the latest year for which worldwid...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Amarin Provides Preliminary 2020 Results and 2021 Outlook Amarin Corporation plcJanuary 7, 2021 GMT Unaudited 2020 Total Net Revenue Estimated to Be Approximately $610 Million, an Increase of Approximately 42% Compared with 2019 Completion of European Regulatory Review and Submission of China Regulatory Application for VASCEPA® (icosapent ethyl) Expected in Late January or February 2021 DUBLIN, Irela...

At 15:03 on an otherwise-normal afternoon in 2014, an 85-year-old male developed a sudden onset of right-sided weakness. Upon witnessing his symptoms, a family member called emergency medical services at 15:08. At 15:13 EMS arrived. The crew’s initial exam demonstrated an alert and oriented 100-kg geriatric male with marked weakness of his right arm and leg. His past medical history included coronary artery disease, chronic obstructive pulmonary disease, deep vein thrombosis status post-IVC f...